Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

42° Mostly Cloudy
- Plymouth, IN (46563)
  Today
  
  Sun and clouds mixed. High 48F. Winds W at 5 to 10 mph..
  
  Tonight
  
  A few clouds. Low around 30F. Winds light and variable.
  
  Updated: December 23, 2025 @ 9:35 am
- Full Forecast

Site search

News
- Local News
- The Leader
Sports
Entertainment
- Local Events
Multimedia
- Photo Galleries
- Videos
Obituaries
Classifieds
The Shopper
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Arvinas, Inc. - Common Stock (NQ:ARVN)

12.29 -0.03 (-0.24%)

Streaming Delayed Price Updated: 10:28 AM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arvinas, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations ↗

June 08, 2023

Arvinas Inc (NASDAQ: ARVN) announced interim data from its Phase 1/2 dose escalation and expansion trial of ARV-766 in metastatic

Via Benzinga

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

Looking Into Arvinas's Return On Capital Employed ↗

May 19, 2023

Via Benzinga

Where Arvinas Stands With Analysts ↗

May 08, 2023

Via Benzinga

Warner Bros. Discovery To Rally Around 62%? Here Are 10 Other Analyst Forecasts For Monday ↗

May 08, 2023

Wells Fargo raised the price target for Stanley Black & Decker, Inc. (NYSE: SWK) from $85 to $90. Wells Fargo analyst Joe O'Dea maintained an Equal-Weight rating. Stanley Black & Decker shares rose 3%...

Via Benzinga

Arvinas: Q1 Earnings Insights ↗

May 05, 2023

Via Benzinga

Arvinas Earnings Perspective: Return On Capital Employed ↗

February 28, 2023

Via Benzinga

6 Analysts Have This to Say About Arvinas ↗

February 24, 2023

Via Benzinga

Where Arvinas Stands With Analysts ↗

January 31, 2023

Via Benzinga

Where Arvinas Stands With Analysts ↗

January 12, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

January 09, 2023

Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows.

Via Benzinga

Looking Into Arvinas's Return On Invested Capital ↗

December 06, 2022

Via Benzinga

Analyst Ratings for Arvinas ↗

November 23, 2022

Via Benzinga

Where Arvinas Stands With Analysts ↗

November 23, 2022

Via Benzinga

Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% ↗

November 23, 2022

Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.

Via Benzinga

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗

November 23, 2022

Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...

Via Benzinga

Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For Autodesk ↗

November 23, 2022

Telsey Advisory Group raised the price target on Abercrombie & Fitch Co. (NYSE: ANF) from $25 to $27. Abercrombie & Fitch shares fell 1.2% to $22.34 in pre-market trading.

Via Benzinga

Arvinas's ARV-471 Achieves Clinical Benefit Rate Of 38% In Breast Cancer Setting ↗

November 22, 2022

Via Benzinga

Carvana, Crocs And Other Big Losers From Monday ↗

November 22, 2022

U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Where Arvinas Stands With Analysts ↗

September 09, 2022

Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗

November 21, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday ↗

October 26, 2022

U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Expert Ratings for Arvinas ↗

September 09, 2022

Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

Arvinas's Return on Invested Capital Insights ↗

August 22, 2022

According to Benzinga Pro data, Arvinas (NASDAQ:ARVN) reported Q2 sales of $31.30 million. Earnings fell to a loss of $70.00 million, resulting in a 10.41% decrease from last quarter.

Via Benzinga

Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock ↗

August 18, 2022

According to Oppenheimer analyst, the fallout of Sanofi SA's (NASDAQ: SNY) amcenestrant creates a buying opportunity for Arvinas Inc (NASDAQ: ARVN)

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Search
Weather

www.thepilotnews.com
218 N. Michigan
Plymouth, IN 46563
Phone: 574-936-3101
Email: webmaster@thepilotnews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Plymouth, IN (46563)

Today

Tonight

Arvinas, Inc. - Common Stock (NQ:ARVN)

Headline News about Arvinas, Inc. - Common Stock

Sections

Services